Moderna, Inc. - Common Stock (MRNA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2025

Type / Class: Equity / Common Stock
Symbol: MRNA on Nasdaq
Shares outstanding: 388,311,585
Price per share: $46.86
All holders as of 31 Dec 2025: Q4 2025
Total 13F shares: 303,423,045
Total reported value: $8,950,917,506
% of total 13F portfolios: 0%
Share change: +25,595,509
Value change: +$767,943,891
Number of holders: 657
Price from insider filings: $46.86

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Moderna, Inc. - Common Stock (MRNA) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
FMR LLC	11%	+49%	$1,217,980,317	+$393,401,259	41,301,469	+48%	FMR LLC	30 Jan 2026
BAILLIE GIFFORD & CO	5.3%	-17%	$814,988,354	-$172,974,542	20,580,514	-18%	BAILLIE GIFFORD & CO	31 Dec 2025

As of 31 Dec 2025, 657 institutional investors reported holding 303,423,045 shares of Moderna, Inc. - Common Stock (MRNA). This represents 78% of the company’s total 388,311,585 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Moderna, Inc. - Common Stock (MRNA) together control 63% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution	Ownership %	Shares Held	Share Change %	Portfolio %	Holdings Value
VANGUARD GROUP INC	11%	41,584,782	+0.97%	0.02%	$1,226,335,222
BlackRock, Inc.	8.4%	32,505,733	+10%	0.02%	$958,594,060
FMR LLC	7.2%	28,045,311	+128%	0.04%	$827,056,216
BAILLIE GIFFORD & CO	5.3%	20,580,514	-5.8%	0.5%	$606,919,358
STATE STREET CORP	4.2%	16,365,478	-4.3%	0.02%	$482,617,946
Capital World Investors	3.3%	12,828,040		0.05%	$378,298,900
GEODE CAPITAL MANAGEMENT, LLC	2.4%	9,219,644	-0.32%	0.02%	$271,415,217
MORGAN STANLEY	2.3%	8,870,716	-11%	0.02%	$261,597,450
Theleme Partners LLP	2.1%	8,081,810	+0.16%	16%	$238,332,577
TWO SIGMA ADVISERS, LP	2%	7,729,700	+14%	0.44%	$227,948,853
TWO SIGMA INVESTMENTS, LP	1.9%	7,342,096	-2.5%	0.32%	$216,518,411
Invesco Ltd.	1.8%	7,029,694	-14%	0.03%	$207,305,681
D. E. Shaw & Co., Inc.	1.3%	5,182,759	-16%	0.12%	$152,839,563
Flagship Pioneering, LLC	1.2%	4,632,149	0%	42%	$136,602,075
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1.2%	4,621,558	+7.2%	0.02%	$136,289,758
BNP PARIBAS FINANCIAL MARKETS	1.1%	4,152,432	0%	0.08%	$122,455,220
UBS Group AG	1.1%	4,086,766	-15%	0.02%	$120,518,730
GOLDMAN SACHS GROUP INC	1%	3,950,619	+24%	0.02%	$116,503,752
Alyeska Investment Group, L.P.	0.83%	3,228,531		0.27%	$95,209,379
BANQUE PICTET & CIE SA	0.81%	3,130,724	0%	0.92%	$92,325,051
NORTHERN TRUST CORP	0.77%	3,002,578	+3.3%	0.01%	$88,546,025
NORGES BANK	0.7%	2,702,832		0.01%	$79,706,516
Merck & Co., Inc.	0.59%	2,308,190	0%	25%	$68,068,523
FEDERATED HERMES, INC.	0.56%	2,178,537	-22%	0.11%	$64,245,055
NATIONAL BANK OF CANADA /FI/	0.56%	2,156,275	-20%	0.07%	$63,588,550

Institutional Holders of Moderna, Inc. - Common Stock (MRNA) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	303,423,045	$8,950,917,506	+$767,943,891	$1,286,279,687	$1,214,563,127	$29.49	657
2025 Q3	275,125,683	$7,105,644,631	-$450,789,607	$1,128,519,908	$1,035,847,251	$25.83	634
2025 Q2	291,423,621	$8,041,462,409	+$359,301,164	$953,917,304	$778,127,109	$27.59	663
2025 Q1	278,813,548	$7,903,142,271	-$59,165,632	$879,746,945	$673,661,963	$28.35	678
2024 Q4	276,578,373	$11,499,056,660	+$341,051,932	$1,001,589,736	$786,508,119	$41.58	729
2024 Q3	260,519,054	$17,396,828,362	-$359,670,897	$1,243,213,357	$701,421,710	$66.83	765
2024 Q2	261,395,055	$31,036,767,708	-$43,788,037	$1,431,835,450	$1,094,475,375	$118.75	939
2024 Q1	262,225,074	$27,942,962,472	+$671,576,108	$993,221,671	$1,286,942,056	$106.56	887
2023 Q4	256,350,763	$25,504,353,761	+$907,888,206	$1,079,174,407	$1,499,592,291	$99.45	869
2023 Q3	246,373,071	$25,443,040,671	-$303,969,124	$1,068,658,896	$1,316,134,609	$103.29	872
2023 Q2	246,506,415	$29,955,571,272	-$272,422,709	$1,008,405,288	$874,358,642	$121.50	942
2023 Q1	249,344,037	$38,273,515,844	+$239,644,701	$1,358,217,438	$1,574,550,446	$153.58	996
2022 Q4	248,479,248	$44,642,318,628	+$419,105,140	$2,336,618,593	$2,478,808,951	$179.62	1,049
2022 Q3	246,689,392	$29,178,218,716	+$223,399,465	$1,254,027,475	$1,052,298,869	$118.25	882
2022 Q2	244,256,119	$34,891,994,437	-$466,757,538	$1,485,721,310	$1,271,813,410	$142.85	957
2022 Q1	248,043,088	$42,733,575,812	+$209,409,354	$2,950,839,880	$2,493,864,042	$172.26	983
2021 Q4	246,080,857	$62,455,582,704	-$6,658,229	$6,423,558,004	$4,434,992,654	$253.98	1,078
2021 Q3	225,302,088	$86,681,348,769	+$6,751,024,992	$8,721,579,062	$7,515,706,532	$384.86	1,120
2021 Q2	207,880,167	$48,837,794,090	+$5,169,371,723	$4,129,479,856	$3,516,026,784	$234.98	873
2021 Q1	188,072,205	$24,617,994,062	+$2,907,518,589	$2,100,566,245	$1,820,607,735	$130.95	752
2020 Q4	168,732,531	$17,626,423,609	-$527,763,419	$1,688,796,948	$1,263,437,595	$104.47	688
2020 Q3	204,933,447	$14,493,668,331	-$999,957,835	$707,320,000	$543,636,000	$70.75	535
2020 Q2	219,125,612	$14,064,229,526	+$1,607,162,122	$355,581,000	$412,038,000	$64.21	477
2020 Q1	195,768,954	$5,863,724,828	+$637,559,905	$54,867,000	$94,208,000	$29.95	285
2019 Q4	174,185,916	$3,406,689,342	+$267,799,940	$5,709,000	$16,926,000	$19.56	157
2019 Q3	109,780,342	$1,747,630,941	+$415,283,859	$5,800,000	$15,038,000	$15.92	131
2019 Q2	84,483,070	$1,235,871,867	+$117,389,510	$5,655,000	$15,100,000	$14.64	128
2019 Q1	79,523,801	$1,604,234,442	+$101,479,383	$5,809,000	$5,868,000	$20.35	101
2018 Q4	133,583,585	$2,019,181,000	+$2,019,011,980			$15.27	75